AbCellera Biologics On Track For Largest Percent Increase Since August 2022 -- Data Talk

Dow Jones
2025/01/23

AbCellera Biologics, Inc. (ABCL) is currently at $3.58, up $0.53 or 17.16%

 

--Would be highest close since June 7, 2024, when it closed at $3.62

--On pace for largest percent increase since Aug. 10, 2022, when it rose 20.07%

--Currently up four of the past five days

--Currently up three consecutive days; up 21.94% over this period

--Best three day stretch since the three days ending Aug. 12, 2022, when it rose 23.13%

--Up 22.35% month-to-date

--Up 22.35% year-to-date

--Down 93.91% from its all-time closing high of $58.90 on Dec. 11, 2020

--Down 31.84% from 52 weeks ago (Jan. 24, 2024), when it closed at $5.26

--Down 35.87% from its 52-week closing high of $5.59 on Jan. 29, 2024

--Up 50% from its 52-week closing low of $2.39 on Sept. 6, 2024

--Traded as high as $3.68; highest intraday level since June 7, 2024, when it hit $3.76

--Up 20.26% at today's intraday high; largest intraday percent increase since Aug. 10, 2022, when it rose as much as 23.67%

 

All data as of 2:49:14 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

January 22, 2025 14:52 ET (19:52 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10